Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

Arch Manning was just as potent with his legs as with his arms. That combination carried 14th-ranked Texas to a 41-27 victory ...

Palantir has been one of the best growth stories in the market. UiPath is just beginning to see its revenue growth accelerate ...

Tens of thousands of Nova Scotia Power customers spent much of Saturday without power after high winds and rain hit the province overnight. According to a statement from the utility, about 186,000 ...

Portable power stations are handy for backup power during outages, off-grid electricity for an RV, or simply charging your laptop and phone while working remotely. They’re effectively large bundles of ...

Oklahoma City's recent struggles drop it from No. 1 for the first time all season as the Top 10 undergoes changes aplenty. As an action-packed 5-game Christmas Day slate awaits, here's where all 30 ...

Caroline Banton has 6+ years of experience as a writer of business and finance articles. She also writes biographies for Story Terrace. Robert Kelly is managing director of XTS Energy LLC, and has ...